___

• Andari Sawaya R, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab 2012; 13: 1345–55.
• Lee WB, Hamilton SM, Harris JP, et al. Ocular complications of hypovitaminosis a after bariatric surgery. Ophthalmology 2005; 112: 1031–4.
• Cay F, Duran A. Predictive factors of success in sleeve gastrectomy: one-year follow-up and the significance of HALP score. J Coll Physicians Surg Pakistan 2021; 31: 1406–11.
• Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 2006; 91: 4223–31.
• Choi HR, Kim NH, Lee J-M, et al. Risk factors ınfluencing the occurrence and severity of symptomatic dry eye syndrome: a cross-sectional study. Ophthalmic Epidemiol 2021: 1–7.
• Osae EA, Bullock T, Chintapalati M, et al. Obese mice with dyslipidemia exhibit meibomian gland hypertrophy and alterations in meibum composition and aqueous tear production. Int J Mol Sci 2020; 21: 1–20.
• Baser G, Yildiz N, Calan M. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res 2017; 42: 661–5.
• Brandão Lpn De A, Vılar L, Cavalcantı BM, et al. Serum levels of vitamin A, visual function and ocular surface after bariatric surgery. Arq Gastroenterol 2017; 54: 65–9.
• Marques NPN, Felberg S, De Barros JN, et al. Evaluation of the ocular surface following bariatric surgery. Arq Bras Oftalmol 2017; 80: 247–51.
• Cushman M, Yanez D, Psaty BM, et al. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the cardiovascular health study. Am J Epidemiol 1996; 143: 665–76.
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf 2017; 15: 575–628.
• Yorek MS, Obrosov A, Shevalye H, et al. Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice. J Peripher Nerv Syst 2015; 20: 24–31.
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793–801.
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98–107.
• Chawla A, Nguyen KD, Goh YPS. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738–49.
• Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85–97.
• Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–15.
• Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415–45.
• Reliability and Validity of Turkish Translation of the Ocular Surface Disease Index (OSDI) in Dry Eye Syndrome | IOVS | ARVO Journals, https://iovs.arvojournals.org/article.aspx?articleid =2382614 (accessed 11 October 2020).
• Kim HT, Kim JM, Kim JH, et al. Relationships between anthropometric measurements and ıntraocular pressure: The Korea National Health and Nutrition Examination Survey. Am J Ophthalmol 2017; 173: 23–33.
• Tiruvalluru M, Ananthathmakula P, Ayyalasomayajula V, et al. Vitamin A supplementation ameliorates obesity-associated retinal degeneration in WNIN/Ob rats. Nutrition 2013; 29: 298–304.
• West SD, Turnbull C. Obstructive sleep apnoea. Eye (Basingstoke) 2018; 32: 889–903.
• Servioli L, Maciel G, Nannini C, et al. Association of smoking and obesity on the risk of developing primary Sjögren syndrome: A Population-based Cohort Study. J Rheumatol 2019; 46: 727–30.
• Baudouin C, Irkeç M, Messmer EM, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmologica 2018; 96: 111–9.